|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 35.62 USD | -1.27% |
|
+2.24% | -23.11% |
| 10:06pm | Collegium Pharmaceutical to Relocate HQ to One Lincoln in Boston | MT |
| 05-16 | Collegium Pharmaceutical, Inc. Announces Appointment of Michael Donovan as Director | CI |
| Market Cap | 1.17B 1.03B 948M 872M 1.65B 113B 1.67B 11.34B 4.44B 55.21B 4.39B 4.3B 190B | P/E 2026 * |
13.6x | P/E 2027 * | 9.67x |
|---|---|---|---|---|---|
| Enterprise Value | 1.92B 1.68B 1.56B 1.43B 2.7B 185B 2.74B 18.61B 7.3B 90.64B 7.21B 7.06B 312B | EV / Sales 2026 * |
2.21x | EV / Sales 2027 * | 1.74x |
| Free-Float |
77.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Collegium Pharmaceutical, Inc.
| 1 day | -1.27% | ||
| 1 week | +2.24% | ||
| Current month | -1.66% | ||
| 1 month | +6.43% | ||
| 3 months | +3.76% | ||
| 6 months | -25.37% | ||
| Current year | -23.11% |
| 1 week | 34.25 |  | 37.7 |
| 1 month | 32.9 | | 38.5 |
| Current year | 30.13 | | 49.31 |
| 1 year | 29.19 | | 50.79 |
| 3 years | 20.95 | | 50.79 |
| 5 years | 14.04 | | 50.79 |
| 10 years | 7.37 | | 50.79 |
| Manager | Title | Age | Since |
|---|---|---|---|
Vikram Karnani
CEO | Chief Executive Officer | 51 | 12/11/2024 |
Colleen Tupper
DFI | Director of Finance/CFO | 50 | 24/05/2021 |
Thomas Smith
CTO | Chief Tech/Sci/R&D Officer | 65 | 23/03/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Gino Santini
CHM | Chairman | 69 | 15/05/2025 |
John Freund
BRD | Director/Board Member | 72 | 01/02/2014 |
Garen Bohlin
BRD | Director/Board Member | 78 | 01/01/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/6/26 | Fiscal year | Chairman | 17,400 | 0.0536% | ||
| 18/5/26 | Sell | Director | -20 | 0.0001% | ||
| 15/5/26 | Fiscal year | Director | 21,527 | 0.0664% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.27% | +2.24% | +15.17% | +61.23% | 1.17B | |
| -1.54% | -1.63% | +52.54% | +150.66% | 1,051B | |
| -1.20% | -3.07% | +52.01% | +48.38% | 609B | |
| -0.46% | +2.12% | +37.01% | +78.11% | 450B | |
| -0.75% | +0.30% | +29.77% | +21.15% | 330B | |
| -1.52% | -1.19% | +34.46% | +35.35% | 284B | |
| -1.70% | -1.82% | +20.99% | +15.74% | 263B | |
| -0.58% | +1.11% | -20.18% | -40.59% | 223B | |
| -0.27% | +1.52% | +23.68% | +56.90% | 198B | |
| -0.58% | +1.88% | +23.63% | +67.46% | 167B | |
| Average | -0.96% | +0.73% | +26.91% | +49.44% | 357.62B | |
| Weighted average by Cap. | -1.09% | +0.02% | +37.14% | +72.05% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 870M 762M 705M 648M 1.22B 83.88B 1.24B 8.43B 3.3B 41.04B 3.27B 3.2B 141B | 860M 754M 697M 641M 1.21B 82.95B 1.23B 8.33B 3.27B 40.58B 3.23B 3.16B 140B |
| Net income | 108M 94.86M 87.68M 80.64M 152M 10.44B 155M 1.05B 411M 5.11B 406M 398M 17.59B | 158M 139M 128M 118M 223M 15.27B 226M 1.53B 601M 7.47B 594M 581M 25.73B |
| Net Debt | 751M 658M 608M 559M 1.06B 72.41B 1.07B 7.27B 2.85B 35.43B 2.82B 2.76B 122B | 328M 287M 265M 244M 461M 31.6B 468M 3.17B 1.24B 15.46B 1.23B 1.2B 53.27B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/07/26 | US$35.60 | -1.33% | 139,611 |
| 17/07/26 | US$36.08 | -0.52% | 316,576 |
| 16/07/26 | US$36.27 | -1.23% | 379,954 |
| 15/07/26 | US$36.72 | +4.85% | 623,962 |
| 14/07/26 | US$35.02 | +0.57% | 552,746 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- COLL Stock
Select your edition
All financial news and data tailored to specific country editions
